Rapamycin dose-response for S6K1-T389 shifts rightward with age: higher EC50, mTORC1 harder to inhibit. Simulated data, literature-grounded trend.

Rapamycin dose-response for S6K1-T389 shifts rightward with age: higher EC50, mTORC1 harder to inhibit. Simulated data, literature-grounded trend.
Aging’s Special Collection on Cell Senescence and Rapamycin:
https://www.aging-us.com/special-collections-archive/cell-senescence-and-rapamycin
#aging #senescence #rapamycin #research #science #meded #openaccess #publications
🎧 Listen to our #PressRelease on the #Essay, titled "Misha Blagosklonny: a life of ideas."
#MikhailBlagosklonny #Podcast #Audio #SoundCloud #PaperSpotlight #Aging #Lifespan #Longevity #Rapamycin #OA #PeerReviewed #Publishing #Press
🔆 #PaperSpotlight:
A new #Essay was recently #Published in Volume 18, titled "Misha Blagosklonny: a life of ideas."
#PressRelease ⬇️
https://bit.ly/4qaj1k0
#MikhailBlagosklonny #Aging #Longevity #Gerontology #Rapamycin #HealthyAging #Press #OA #PeerReviewed #Publishing
🔬 Aging Special Collection on Cancer and mTOR:
https://www.aging-us.com/special-collections-archive/cancermtor
#aging #cancer #mTOR #rapamycin #research #science #meded #openaccess #publications #collections
#Rapamycin Boosts Brain Blood Flow in #Alzheimer’s Gene Carriers
#Neurology #Neuroscience
#Rapamycin Boosts Brain Blood Flow in #Alzheimer’s Gene Carriers
#Neurology #Neuroscience
⏳ Aging’s Special Collection on Longevity and Rapamycin:
https://www.aging-us.com/special-collections-archive/longevity-and-rapamycin
#aging #longevity #rapamycin #research #science #meded #openaccess #publications #publishing
🧬 Longevity & Aging Series (S3, E6):
Girish Harinath from AgelessRx discusses “Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results.”
🎥 https://www.youtube.com/watch?v=7-NvskI8Ve0
#interview #aging #rapamycin #geroscience #longevity #healthspan #series #meded
🔬 Aging Special Collection on Cancer and mTOR:
https://www.aging-us.com/special-collections-archive/cancermtor
#aging #cancer #mTOR #rapamycin #research #science #meded #openaccess #publications #collections
Epigenetics Update - Rapamycin targetome mining identifies RBBP7 as a druggable epigenetic vulnerability in hepatocellular carcinoma u.epigenome.us/jje91JhP
Bing Shan & Yaoyang Zhang (CAS) in Cell Chemical Biology
✅ A recent essay published in Aging, “Misha Blagosklonny: a life of ideas,” explores his life, scientific legacy, and groundbreaking ideas on aging, hyperfunction, rapamycin, and longevity.
🔗 Summary:
https://bit.ly/4iu38Dd
#Blagosklonny #Aging #Longevity #Rapamycin #Lifespan
⏳ Aging’s Special Collection on Longevity and Rapamycin:
https://www.aging-us.com/special-collections-archive/longevity-and-rapamycin
#aging #longevity #rapamycin #research #science #meded #openaccess #publications #publishing
🔬 Aging Special Collection on Cancer and mTOR:
https://www.aging-us.com/special-collections-archive/cancermtor
#aging #cancer #mTOR #rapamycin #research #science #meded #openaccess #publications #collections
Aging’s Special Collection on Cell Senescence and Rapamycin:
https://www.aging-us.com/special-collections-archive/cell-senescence-and-rapamycin
#aging #senescence #rapamycin #research #science #meded #openaccess #publications